...
首页> 外文期刊>Endocrine. >Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases
【24h】

Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases

机译:全甲状腺切除术,不进行预防性中央淋巴结清扫术,用于治疗分化型甲状腺癌。 221例临床回顾性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Total thyroidectomy (TT) is the standard of care for differentiated thyroid cancer (DTC), but still there is no consensus about the role of routine use of prophylactic central lymph node dissection. The aim of this study was to analyze our results of TT without prophylactic central lymphadenectomy in the treatment of DTC. Clinical records, between January 1998 and December 2005, of 221 patients undergoing TT, without prophylactic central lymph node dissection, were retrospectively evaluated. Two hundred and eleven patients (95.47 %) also underwent radio-iodine (RAI) ablation followed by thyroid stimulating hormone (TSH) suppression therapy. In patients with loco-regional lymph nodal recurrence, lateral and central lymph node dissection was performed. The incidence of permanent hypoparathyroidism (iPTH <10 pg/ml) and permanent vocal fold paralysis were, respectively, 0.91 and 0.91 %. After a 9.6 +-3.5 years mean follow-up, the Tate of loco-regional recurrence, with positive cervical lymph nodes, was 3.16 % (7/221 patients). In these cases a lateral and central lymphadenectomy was carried out without significant complications. Our results showed that TT without prophylactic central lymph node dissection, followed by RAI ablation, was associated~with low morbidityWd low loco-regional recurrence rate, even if the lack of a control group treated with TT plus prophylactic central lymphadenectomy suggests caution against generalization of our assumption. Such last combined procedure could be indicated in high-risk patients, in whom loco-regional recurrence is more frequent. However, given the trend in the literature toward prophylactic lymphadenectomy and the avoidance of RAI treatment, prospective randomized trials should be conducted to better clarify this issue.
机译:全甲状腺切除术(TT)是分化型甲状腺癌(DTC)的治疗标准,但对于常规使用预防性中央淋巴结清扫术的作用尚无共识。这项研究的目的是分析我们在不进行预防性中央淋巴结清扫术的DTC治疗中的TT结果。回顾性分析了1998年1月至2005年12月间221例未经预防性中央淋巴结清扫的TT患者的临床记录。 211名患者(95.47%)也接受了放射性碘(RAI)消融,然后进行甲状腺刺激激素(TSH)抑制治疗。在局部区域淋巴结复发的患者中,进行了侧面和中央淋巴结清扫术。永久性甲状旁腺功能减退(iPTH <10 pg / ml)和永久性声带麻痹的发生率分别为0.91和0.91%。在平均9.6±-3.5年的随访之后,局部淋巴结复发且颈部淋巴结阳性的Tate为3.16%(7/221例)。在这些情况下,进行了侧面和中央淋巴结清扫术,没有明显的并发症。我们的研究结果表明,即使不进行TT加预防性中央淋巴结清扫术的对照组,提示未进行预防性中央淋巴结清扫术且随后进行RAI消融的TT与低发病率和低局部复发率相关。我们的假设。这种最后的联合手术可以在局部区域复发较频繁的高危患者中使用。但是,鉴于文献中有预防性淋巴结清扫术的趋势以及避免使用RAI治疗,应进行前瞻性随机试验以更好地阐明这一问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号